Search alternatives:
significantly mediated » significantly predicted (Expand Search), significantly related (Expand Search), significantly reduced (Expand Search)
mediated release » mediated defense (Expand Search), mediated diseases (Expand Search), mediated response (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 21 - 40 results of 19,058 for search '(( significantly ((better decrease) OR (mean decrease)) ) OR ( significantly mediated release ))', query time: 1.28s Refine Results
  1. 21
    Sketch of significant inflammatory/profibrogenic mediators in p28 <i>Reeler</i> vitreous.

    Sketch of significant inflammatory/profibrogenic mediators in p28 <i>Reeler</i> vitreous. by Bijorn Omar Balzamino (303576)

    Published 2019
    Save to List
    Saved in:
  2. 22
    The mean values of blood gas analysis during storage (<i>n</i> = 10).

    The mean values of blood gas analysis during storage (<i>n</i> = 10). by Junko Ichikawa (12542602)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 23
    The mean complete blood counts and coagulation profiles during storage (<i>n</i> = 9).

    The mean complete blood counts and coagulation profiles during storage (<i>n</i> = 9). by Junko Ichikawa (12542602)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 24
    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells.

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”
    Save to List
    Saved in:
  5. 25
    AZ10606120 treatment does not significantly increase apoptosis mediated cell death.

    AZ10606120 treatment does not significantly increase apoptosis mediated cell death. by Matthew Drill (22258391)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.

    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

    Published 2025
    Subjects: “…treatment initiation decreased…”
    Save to List
    Saved in:
  7. 27
    ATP release analysis.

    ATP release analysis. by Marie Amate (21433166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Fig 4 -

    Fig 4 - by Hassan Mehmood (9574947)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 29
    Fig 3 -

    Fig 3 - by Hassan Mehmood (9574947)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 30
    Fig 2 -

    Fig 2 - by Hassan Mehmood (9574947)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 31
    Fig 1 -

    Fig 1 - by Hassan Mehmood (9574947)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 32
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 33
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 34
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 35
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 36
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 37
    S1 Data -

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 38
    Clinical course of patient no.

    Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 39
    Socio-demographic characteristics of women in study sample (means except as noted).

    Socio-demographic characteristics of women in study sample (means except as noted). by Chelsea Ducille (21540080)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 40
    Dissimilar target/nontarget population responses relate to better subsequent performance on probe trials.

    Dissimilar target/nontarget population responses relate to better subsequent performance on probe trials. by Alice Berners-Lee (15354255)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: